Patent · US Active

Pharmaceutical formulation for histone deacetylase inhibitors

US10258595B2 · kind B2 · utility

0Cited by
8References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 29, 2017
Grant dateApr 16, 2019
Priority date—
Expiry dateJun 29, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C259/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A pharmaceutical composition, comprising a therapeutically effective amount of an active pharmaceutical ingredient (API) compound represented by the following structural formula

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.